What is the difference between Optical brightener (OB) and Optical Brightener -1(OB-1)
Optical brightener (OB) and Optical Brightener -1(OB-1) are brightening agents that are often confused. Both are used for brightening but on different types of materials.
Mar 20，2024 Organic reagents
Levonorgestrel-Ethinyl Estradiol Oral: uses and side effects
This combination hormone medication Levonorgestrel-Ethinyl Estradiol is used to prevent pregnancy.
Mar 20，2024 API
Gadolinium Oxide: Optical Properties, Synthesis Routes and Toxicity
Gadolinium oxide boasts excellent optical qualities for imaging applications but poses toxicity risks, including eye irritation, harm to aquatic life, and fibrogenic effects.
Mar 20，2024 API
Altrenogest: Overview, Effects on Reproductive Performance and Environmental Photochemistry
Altrenogest is used for estrous synchronization in gilts and sows. It undergoes rapid photolysis in the environment, posing potential ecological risks.
Mar 20，2024 API
Ostarine: Overview and Clinical Efficacy
Ostarine, a selective androgen receptor modulator, enhances muscle growth and fat loss, lacks FDA approval, and requires careful use and post-cycle therapy for sustained benefits.
Mar 20，2024 API
Cymoxanil: Overview, Therapeutic Effects and Applications in Liposome Nanocarriers
Sterosomes enhance Cymoxanil's stability and efficacy, offering innovative solutions to its degradation challenges in agricultural disease management.
Mar 20，2024 API
The mechanism of action of Dihexa
Dihexa has become a pioneering peptide drug that can address neurodegenerative diseases, including Alzheimer's disease.
Mar 20，2024 API
O-Mesitylenesulfonylhydroxylamine: A Keystone in Organic Synthesis
O-Mesitylenesulfonylhydroxylamine emerges as a pivotal reagent in the domain of organic chemistry.
Mar 20，2024 API
Hemoglobin: Unveiling Allosteric Mechanisms for Enhanced Oxygen Transport
Hemoglobin transports oxygen in vertebrates, modulated by allosteric effects and structural changes, essential for developing medical Hemoglobin-Based Oxygen Carriers.
Mar 20，2024 API
Prucalopride Succinate: Pharmacodynamics, Pharmacokinetic Properties and Adverse Effects
Prucalopride Succinate effectively treats chronic constipation with good absorption, high bioavailability, minimal metabolism, and mild adverse effects.
Mar 20，2024 API